Nicole Dale

Pharma Writer, Pharmatica
  • South Africa
  • Joined 2026
3 Followers
6 Following

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

  • Read Why Does the True Impact of AI in Drug Discovery Lag?
    • AI Drug Discovery
    • AI & Machine Learning
    • AI Drug Development
    • Drug Discovery
    • Drug Design & Delivery
    • Orphan Drugs
    • Small Molecules
    • Biomedical R&D
    • pharma R&D
    • Pharmaceutical R&D
    • Preclinical Development
    • Pharmacology
    • Machine Learning in Pharma
    • LLMs in Pharma
    • Pharma Regulation
    • AI governance
    • AI Pharma
    • Computational Biology
    • Genetics & Molecular Biology
    • Cell and Gene Therapy
    • Tech and Innovation
    • Biotech
    • Investment and Market Analysis
    • Pharmatica
    • pharmaceutical industry
    • Pharma Intelligence
    • Pharma Policy
    • The Discovery Loop
    • Translational & Pre-clinical Research
    • Research Informatics
    • Precision Medicine

    Why Does the True Impact of AI in Drug Discovery Lag?

  • Read Bioprocessing Is Becoming a Smarter Manufacturing System
    • Bioprocessing
    • Drug Production
    • AI and Automation
    • HTS and Automation
    • Continuous Manufacturing
    • Contract Manufacturing (CDMO/CMO)
    • Decentralised Manufacturing
    • Sterile Manufacturing
    • Biologics
    • Cell and Gene Therapy
    • Advanced Therapies
    • Pharma Supply Chains
    • Supply Network Strategy
    • AI Pharma
    • AI & Machine Learning
    • AI Drug Development
    • CMC
    • Trial Operations & CMC
    • Quality
    • Quality Assurance & cGMP
    • ALCOA
    • Pharmaceutical Compliance

    Bioprocessing Is Becoming a Smarter Manufacturing System

  • Read What Sponsors Need to Know About UK Combined Review 2026
    • Clinical Trial Regulation
    • Pharma Policy
    • Drug Approval
    • Pharma Regulation
    • Global Regulatory Affairs
    • Regulatory & IP
    • Clinical Logistics
    • clinical trials
    • Clinical Trial Strategy
    • Adaptive Clinical Trials
    • Medical Governance
    • Commercialisation & Medical Affairs
    • Advanced Therapies
    • Patient Enrolment
    • Trial Operations & CMC
    • Supply Network Strategy

    What Sponsors Need to Know About UK Combined Review 2026